Amelioration of polycystic ovary syndrome-related disorders by supplementation of thymoquinone and metformin

Middle East Fertility Society Journal

Table 2 Comparison between the two studied groups in number of patients with oligomenorrhea or amenorrhea

Number of patients with oligomenorrhea or amenorrhea	At the beginning of the study	After 3 months	After 6 months	P1	P2	P3
Group A	104 (100%)	93 (89.4%)	61 (58.6%)	0.42	0.0008**	0.01*
Group B	103 (100%)	91 (88.3%)	39 (37.8%)	0.38	0.00**	0.00**
P	----	0.93	0.031*

*Statistically significant
**Highly significant (≤ 0.001)
P1, beginning of the study compared to after 3 months; P;2, beginning of the study compared to after 6 months; P3, after 3 months compared to after 6 months